AVTX

NASD Avalo Therapeutics Inc
Oct 16, 2026 · 2:46 AM ET EOD Market Closed

$12.01 ↑ +0.00 (+0.00%) Trading Up from the previous close of $12.01, $0.34 below the day’s high of $12.35

YTD change
-33.87%
vs 20-day SMA
-18.38%
vs 200-day SMA
-27.26%

Price ranges

Previous day
$11.58 $12.12
open $11.91 close $11.84
-$0.07 (-0.59%)
Today
$11.70 $12.35
open $11.93 now $12.01
+$0.08 (+0.67%)
Past week
$11.58 $13.82
from $13.58 now $12.01
-$1.57 (-11.56%)
Past month
$11.58 $17.19
from $16.58 now $12.01
-$4.57 (-27.56%)
This year
$11.58 $24.27
from $18.16 now $12.01
-$6.15 (-33.87%)

Price & Performance

-1.34 (-10.04%) / 6M

$10.96$15.22$19.49$23.75Apr 15Jul 16Oct 15

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.9% away from all-time highs of $9,331.20
  • AVTX is down 34% since the beginning of the year
  • AVTX is down 14% over the past 12 months
  • AVTX is down 28% over the past 1 month
  • 21% of all AVTX investors are betting against AVTX

AVTX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -13.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.83
Earnings momentum -39.6% Quarterly EPS growth
Quarterly change -39.6%

Valuation

P/E ratio N/A
Enterprise value $118.2M
Beta 0.79

Balance sheet & scale

IncomeN/A
Revenue$59.0K
Cash$400.3M
Debt$2.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $644.1M

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $434.03 +1.86%
MRNA Moderna, Inc. $236.50 +4.51%
RVMD Revolution Medicines, Inc. $189.26 -2.20%
ROIV Roivant Sciences Ltd. $34.04 +1.25%
BNTX BioNTech SE Sponsored ADR $90.20 +1.74%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.